Δευτέρα 24 Απριλίου 2017

FDA grants marketing approval to scalp cooling system for breast cancer chemotherapy patients

The U.S. Food and Drug Administration (FDA) has cleared marketing of the Paxman Scalp Cooling System, a scalp cooling technology that was developed to reduce hair loss in breast cancer patients undergoing chemotherapy. The approval is based on the same...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oDiSWV
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις